Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06UOL
|
|||
Former ID |
DIB015688
|
|||
Drug Name |
PIROTIODECANE
|
|||
Synonyms |
HPE-101; 1-[2-(Decylsulfanyl)ethyl]pyrrolidin-2-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Ophthalmic graves disease [ICD-11: 5A02.0; ICD-10: E05.0, H06.2] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H31NOS
|
|||
Canonical SMILES |
CCCCCCCCCCSCCN1CCCC1=O
|
|||
InChI |
1S/C16H31NOS/c1-2-3-4-5-6-7-8-9-14-19-15-13-17-12-10-11-16(17)18/h2-15H2,1H3
|
|||
InChIKey |
VDPRSOCKHVPZRS-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 113855-10-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Potential penetration (PP) | Target Info | Modulator | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Effectiveness of pirotiodecane, absorption enhancer, on nasal absorption in rabbits. Drug Metab Pharmacokinet. 2005 Feb;20(1):65-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.